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Purpose: To analyze the expression of apoptosis and cell proliferation molecules in pterygium tissues of Chinese patients.
Methods:  Thirty-three  pterygia  were  surgically  removed  using  the  bare  sclera  procedure,  and  23  normal  bulbar
conjunctivas  were  also  obtained.  Formalin-fixed,  paraffin-wax-embedded  tissues  were  analyzed  by
immunohistochemistry with anti- proliferating cell nuclear antigen (PCNA), Ki-67 (a proliferating cell marker), mutant
p53 (mP53), Bcl-2 associated X-protein (BAX), B-cell lymphoma gene 2 (Bcl-2), and caspase-3 antibodies. Terminal
deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling assay (TUNEL) analysis was used to analyze the
apoptotic cells.
Results: Our study revealed that the positive rate of PCNA and Ki-67 significantly increased in the pterygium samples
compared to the normal conjunctiva samples. In the molecules involved in apoptosis, the results showed that the positive
rate of Bcl-2 and mP53 significantly increased in the pterygium samples. However, no difference was found between the
pterygium and normal conjunctiva samples in the expression of Bax and caspase-3. Through TUNEL analysis, apoptotic
cells were seen in the entire width of the epithelial layer in normal conjunctivas but were found mainly confined to the
outer layer of the epithelial cells in pterygia.
Conclusions: The finding of high levels of cellular proliferation and low levels of cellular apoptosis in pterygia confirmed
that both cell apoptosis and proliferation are known to play an important role in human pterygium pathogenesis.
Pterygium is one of the most commonly seen diseases in
ophthalmology.  It  is  a  fibrovascular  neoformation
characterized by a triangular or wing-shaped overgrowth of
abnormal conjunctiva onto the cornea and is composed of
epithelium  and  highly  vascular,  subepithelial,  loose
connective tissue [1]. In severe cases, a pterygium can grow
into the central cornea, which can induce irregular corneal
astigmatism, resulting in loss of vision [2]. It frequently recurs
after resection.
The pathogenesis of pterygia has not yet been clarified.
Pterygia  show  significant  differences  from  bulbar
conjunctivas, both in the epithelium and in the underlying
connective tissue [3]. Pterygia share many similar traits with
tumors, such as cell proliferation, invasion of the cornea, and
recurrence after resection [4]. Recurrent pterygium is more
common in younger patients and is often associated with a
family history of pterygium. It also requires sophisticated
surgery [5]. Recently, pterygium has been thought to be an
uncontrolled cell proliferation [6]. Kase et al. [7] showed that
pterygium growth and development were associated with the
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proliferation  of  the  epithelium.  Other  researchers  have
determined that pterygium is a disorder of excessive cellular
proliferation in the fibrovascular layer [8]. Still others have
shown similar cellular proliferation patterns between pterygia
and conjunctivas [9]. Tan et al. [10] examined pterygium
specimens for the pattern of expression of genes known to be
involved in the regulation of apoptosis, and they drew the
conclusion that pterygia were a result of disruption of the
normal process of apoptosis. We designed the current study
to  determine  whether  cellular  proliferation  or/and  cellular
apoptosis participate in the pathogenesis of pterygia.
In this study, we examined the expression biomarkers of
proliferation  (proliferating  cell  nuclear  antigen  [PCNA],
Ki-67  [a  proliferating  cell  marker])  and  apoptosis  (Bcl-2
associated  X-protein  [BAX],  B-cell  lymphoma  gene  2
[Bcl-2], caspase-3, and mutant p53 [mP53]) in pterygia and
normal  conjunctivas  by  immunohistochemistry.  We  also
directly  observed  apoptotic  cells  by  TUNEL  (terminal
deoxynucleotidyl  transferase-mediated  dUTP  nick  end
labeling) analysis.
METHODS
Patients and controls: Informed consent was obtained from
all individuals who participated in this study. The study group
included 33 cases of surgically excised pterygium (19 males
and 14 females) with an age range of 43–79 years and an
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1687average age of 66.3 years. All patients underwent excision by
the bare sclera technique. The normal group comprised 23
individuals (12 males and 11 females) with an age range of
47–81 and an average age of 66.9 who had other eye diseases
but  exhibited  no  characteristics  of  pterygium.  Normal
conjunctiva  samples  were  collected  from  the  superior
conjunctivas of the normal group individuals during their
cataract  or  vitreoretinal  surgery.  All  patients  underwent  a
complete ophthalmic examination.
Immunohistochemistry  study:  All  sections  were
deparaffinized in xylene, sequentially rehydrated in alcohol,
and washed in phosphate-buffered saline. The sections were
heated twice in a microwave oven for 5 min in citrate buffer
(pH  6.0)  for  antigen  retrieval.  Anti-PCNA  monoclonal
antibody (1:300; Santa Cruz Biotechnology Inc., Santa Cruz,
CA),  rabbit  polyclonal  anti-Ki-67  antibody  (prediluted;
Zhongshan biologic and technical company, Beijing, China),
rabbit polyclonal anti-Bax (p19), anti-Bcl-2 (c21) antibody
(1:150;  Santa  Cruz),  anti-caspase-3  (1:70;  Zhongshan
biologic and technical company), and anti mutant p53 (1:400;
Santa Cruz) were used as the primary antibody. Briefly, the
incubation was at 4 °C overnight, followed by washing with
PBS. The sections were incubated with secondary antibody
for 30 min at room temperature. Signals were developed with
3,3’-diaminobenzine  (DAB)  for  5  min  and  counterstained
with hematoxylin [11,12]. Negative controls were performed
with  normal  mouse  or  rabbit  sera  diluted  at  the  same
concentration as the primary antibody.
TUNEL analysis: For TUNEL staining, tissue sections were
deparaffinized,  rehydrated  through  a  series  of  graded
alcohols, and washed in distilled water followed by PBS.
Subsequently,  the  sections  were  permeabilized  using
proteinase K (20μg/ml, 20 min at room temperature), washed
in PBS, incubated in 2% H2O2 in 0.1 M PBS for 30 min at
room temperature to quench endogenous peroxidase activity,
and  treated  with  Triton-X.  The  terminal  deoxynucleotidyl
transferase-mediated  dUTP  nick  end  labeling  (TUNEL)
reaction  was  performed  using  a  cell  death  kit  (Roche,
Mannheim, Germany). Briefly, the slides were incubated with
TUNEL reaction mixture for 60 min (humid chamber, 37 °C)
and then washed twice in PBS. After multiple washing steps,
the sections were treated with Converter-POD solution for 30
min (humid chamber, 37 °C), rinsed with PBS, and visualized
by adding 3,3′-diaminobenzine (DAB) for 10 min at room
temperature.  They  were  then  washed  in  phosphate  buffer
saline (PBS), counterstained using hematoxylin staining, and
finally,  mounted  for  light  microscopic  observation.  For
negative controls, sections were incubated with label solution
only (without terminal transferase) instead of the TUNEL
reaction mixture.
Ki-67 positive cell counting: All pterygium basal epithelial
cells  were  counted  and  positive  staining  cells  of  five
microscopic fields (400×) from each tissue was performed.
Then, positive staining cells were noted by their labeling index
as a percentage in each specimen, and the measurements were
averaged [13].
Statistical analysis: SPSS (the Statistical Package for Social
Sciences) 13.0 (SPSS Inc., Chicago, IL) was used for data
analysis,  and  p<0.05  was  considered  to  be  significant.
Wilcoxon rank sum test and χ2 test were used to detect the
data.  When  the  qualification  of  χ2  test  wasn't  satisfied,
continuity correlation was used to modify the results.
RESULTS
In this study, we tested the expression of the proliferation-
related genes Ki-67 and PCNA and the apoptosis genes p53,
Bcl-2, and Bax in 33 samples of pterygia and 23 samples of
normal  conjunctivas.  The  results  are  shown  in  Table  1.
TUNEL  methodology  was  used  to  test  the  evidence  of
apoptotic cells.
Ki-67 protein expression was observed in all pterygium
cases and all normal conjunctiva cases. However, the number
of immunopositive cells in the epithelial layer of pterygia
(14.27±4.43) was significantly higher than that in normal
conjunctivas  (4.26±2.42,  p<0.01;  Table  2,  Figure  1A,B).
PCNA-positive immunostaining was evaluated in 24 of the 33
cases of pterygia and 7 of the 23 cases of normal conjunctiva.
TABLE 1. NUMBER OF POSITIVE AND NEGATIVE RESULTS FOR CELL PROLIFERATION AND APOPTOSIS BIOMARKERS IN PTERYGIUM AND
CONJUNCTIVA SAMPLES.
 
Pterygium samples Conjunctiva samples
 
 Factor + - + - p value
PCNA 24 9 7 16 0.002
Ki-67 33 0 23 0 –
mP53 15 18 0 23 0.001
Bcl-2 33 0 2 21 0.000
Bax 33 0 23 0 –
Caspas-3 14 19 13 10 0.299
               +:positive; -: negative; p value: the positive rate of biomarkers in pterygia versus in the conjunctivas.
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1688The positive rate of PCNA was significantly higher in pterygia
than in normal conjunctivas (p=0.002; Table 1, Figure 1C,D).
The expression of mutant p53 was noted predominantly
in  the  basal  layer  of  epithelial  cells.  Mutant  p53-positive
staining was evaluated in 15 of the 33 cases of pterygia and
in 0 of the 23 cases of normal conjunctive. The positive rate
of mutant p53 was significantly higher in pterygia than in
normal conjunctivas (p=0.001; Table 1, Figure 2E,F). Bcl-2-
and Bax-positive staining were noted in the basal epithelial
layer of cells. Bax showed a strong expression throughout the
entire width of the epithelial layer in all of the pterygium and
normal conjunctiva samples (Table 1, Figure 2C,D). Bcl-2
was expressed in the epithelial layer of all the pterygium
samples and in two normal conjunctiva samples. The Bcl-2-
positive  rate  was  significantly  higher  in  the  pterygium
samples  (p=0.000,  Table  1,  Figure  2A,B).  Caspase-3  was
TABLE 2. NUMBER OF CELLS POSITIVE FOR KI-67 IN THE BASAL EPITHELIUM OF PTERYGIUM AND CONJUNCTIVA SAMPLES.
Ki-67 Pterygium (%) Conjunctiva (%)
±S 14.27±4.43 4.26±2.42
p<0.01.
Figure 1. Immunohistochemical staining for Ki-67 and PCNA positive cells in pterygium and normal conjunctiva samples. Positive Ki-67
immunostaining showed higher nuclear staining in pterygia (A) than in normal conjunctivas (B). PCNA immunostaining showed a higher
nuclear staining in pterygia (C) than in normal conjunctivas (D). All slides were counterstained with Mayer’s hematoxylin. Original
magnifications: A-D, 400×.
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1689expressed in the epithelial layer in 14 of the 33 pterygium
samples and 13 of the 23 normal conjunctiva samples. The
positive  rate  of  caspase-3  was  not  significantly  different
between  the  pterygium  and  normal  conjunctiva  samples
(p=0.299, Table 1).
As age may be an important impact factor for apoptosis
and  proliferation  in  conjunctiva  tissue,  we  analyzed  the
relationship  between  age  and  proliferation/apoptosis.  The
patients were divided into two groups (<70, ≥70), and the
results showed that the positive rate of mP53 was significantly
higher  in  the  pterygia  of  the  younger  patients  (Table  3).
However, there was no difference in Capsase-3 or PCNA
between the two age groups. With TUNEL analysis, in the
epithelial layer, apoptotic cells were found mainly confined
to the basal layer of the epithelial cells in pterygium samples
(Figure 2H). In normal conjunctiva samples, the whole width
of the epithelial layer expressed apoptotic cells (Figure 2G).
DISCUSSION
In this study, we tested the expression of two proliferation
markers (PCNA and Ki-67) and four apoptosis-related bio-
markers (mP53, Bcl-2, Bax, and caspase-3) in pterygium and
normal conjunctiva samples. The results showed that positive-
PCNA, mP53, and Bcl-2 rates were significantly increased in
the  pterygium  samples  compared  to  normal  conjunctiva
samples. TUNEL analysis showed that the number of positive
cells was lower in the epithelial layer of pterygia than that in
normal  conjunctivas.  These  results  indicate  that  cell
proliferation and apoptosis are involved in the pathogenesis
of pterygia.
Pterygium, which invades the cornea forming a wing-like
shape, is a proliferative, invasive, and highly vascularized
tissue [14]. Previous studies have shown that appropriate cell
apoptosis, not cell proliferation, plays an important role in the
pathogenesis of pterygia [9,15]. However, studies regarding
cell proliferation in the development of pterygia have also
been  reported  [7,8,16].  The  question  was  therefore  raised
whether  proliferation  or  apoptosis  participate  in  the
pathogenesis of pterygia. This study was designed to clarify
this issue.
In the bio-marker of proliferation, PCNA and Ki-67 were
widely studied, and we chose them as candidate markers to
analyze.  Proliferating  cell  nuclear  antigen  (PCNA)  is  a
cofactor for DNA polymerase δ in both S phase and during
DNA synthesis and is associated with DNA damage-repair
mechanisms. Therefore, the expression of this molecule is
useful  for  cell  proliferation  [17,18].  In  the  present  study,
PCNA was expressed in 24 (72.7%) of the 33 pterygium
samples, but in only 7 (30.4%) of the 23 normal conjunctiva
samples. The rates of positive PCNA were significantly higher
in  the  pterygium  samples  than  in  the  normal  conjunctiva
samples.  This  result  is  generally  consistent  with  previous
reports [7,19]. Because PCNA is just one of the important
molecules that reflect the proliferation of pterygia, we further
investigated  Ki-67  to  test  cell  proliferation.  Our  results
showed that Ki-67 immunopositive cells in the epithelial layer
of  pterygia  were  significantly  higher  than  in  normal
conjunctivas, which is the same result as in previous reports
[13]. As PCNA and Ki-67 are the important bio-markers of
proliferation, our studies revealed that cell proliferation was
involved in the pathogenesis of pterygia.
Although  cell  proliferation  participates  in  the
pathogenesis of pterygia, studies of apoptosis are also needed.
We chose mutant p53, Bcl-2, Bax, and caspase-3 to analyze
apoptosis.  The  mutation  p53  protein  may  lead  to  fixing
genome damage and to decreased cell cycle inhibition or
decreased apoptosis [20]. Consistent with previous reports
[10], we also found that the expression of mutant p53 was
significantly increased in the epithelial layer of pterygium
samples. These results suggest that the increased mutant p53
could  possibly  lead  to  decreased  cell  cycle  inhibition  or
decreased apoptosis in the epithelial layer of the pterygium
[21,22].  Bcl-2  proteins  are  involved  in  the  response  to
apoptosis. Some of these proteins (such as Bcl-2 and Bcl-xl)
are antiapoptotic, whereas others (such as Bak and Bax) are
proapoptotic [23]. In our study, Bcl-2 was expressed in the
epithelial layer of all the pterygium samples and two of the
normal conjunctiva samples. Bax was expressed in all the
pterygium  and  normal  conjunctiva  samples.  It  was  not
difficult to find from the expression of Bcl-2 and Bax that cell
apoptosis in pterygia was weaker than in normal conjunctivas.
If the balance of proapoptotic and antiapoptotic Bcl-2 proteins
is disrupted, it will lead to the formation of the apoptosome
and the activation of the caspases (such as caspases-3 and
caspases-9)  [24].  In  this  study,  there  was  no  significant
difference  in  caspase-3  between  normal  conjunctivas  and
pterygia. Some reasons for this result are that caspase-3 may
be not involved in the pathogenesis of pterygia and that the
samples were selected from different sections of the pterygia.
Apoptotic  cells  could  be  seen  in  the  entire  width  of  the
epithelial layer in normal conjunctivas by TUNEL analysis.
However, apoptotic cells were found mainly confined to the
basal epithelial cells in pterygia; this finding is consistent with
an earlier study [10]. Therefore, we can draw the conclusion
that  cell  apoptosis  participates  in  the  development  of
pterygium.
As age is an important impact factor for proliferation and
apoptosis in conjunctiva tissue, we divided the samples into
two groups according to age (<70, ≥70). The results showed
that the positive rate of mP53 was significantly increased in
pterygia in the younger patients. mP53 protein decreased cell
cycle inhibition and apoptosis, which may be the reason that
pterygium relapses more easily in younger patients.
There were some limitations in our study. The best way
to  determine  whether  caspase-3  is  involved  in  the
pathogenesis of pterygia is to measure pro-caspase 3 and
Molecular Vision 2011; 17:1687-1693 <http://www.molvis.org/molvis/v17/a187> © 2011 Molecular Vision
1690Figure 2. Immunohistochemical staining for Bcl-2, Bax, mutant p53, and TUNEL analysis positive cells in pterygium and normal conjunctiva
samples. Human pterygium tissues (A, C, E, G); Human normal conjunctiva tissues (B, D, F, H). Bcl-2 showed strong expression in the
cytoplasm throughout the entire width of the epithelial layer in pterygium (A). No expression was shown in the epithelial layer of Bcl-2 in
normal conjunctiva (B). Bax showed strong expression in the cytoplasm throughout the entire width of the epithelial layer in both pterygium
(C) and normal conjunctiva (D). mP53 immunostaining showed nuclear staining in the pterygium epithelial layer (E), but no expression in
normal conjunctiva (F). For TUNEL analysis, the positive cells in pterygium showed nuclear staining in the basal layer of the epithelium
(G). In normal conjunctiva, the positive cells showed nuclear staining in the whole width of the epithelial layer (H). All slides were
counterstained with Mayer’s hematoxylin. Original magnifications: A-H, 400×.
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1691active caspase-3, which we intend to do in a further study. In
conclusion, our study suggests that both cell apoptosis and cell
proliferation  processes  are  strongly  associated  with  the
development and progression of pterygia. The mechanisms of
cell  apoptosis  and  cell  proliferation  in  pterygium  are
complicated, and further study is needed.
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